Dutch Lady

 

Business Description and Revenue Segments

Company Overview. Dutch Lady Milk Industries Berhad (DLADY) is a leading halal-certified dairy manufacturer in Malaysia, established in 1963 and listed on Bursa Malaysia in 1968. It is a subsidiary of Royal FrieslandCampina, the Dutch dairy cooperative, which holds a controlling 51% stake. The company manufactures and distributes a wide range of dairy and infant nutrition products tailored for all life stages.

Product Portfolio & Brand Architecture. DLADY markets its products under an extensive brand umbrella that includes Dutch Lady, Dutch Baby, Frisolac, Friso Gold, Frisomum, and Dutch Lady PureFarm. Its product lineup spans UHT liquid milk (Dutch Lady 123/456/6+/Omega 3*6, fresh milk, full cream milk), growing-up milk powders, infant formulas, yoghurt and flavoured milk drinks, as well as offerings for the professional foodservice channel. The company has a distinct beverage-centric focus (versus broader processed dairy), with particularly strong positions in the Ready-to-Drink (RTD) liquid milk segment and the Infant & Toddler Formula (IFT) nutrition category.

Market Leadership. Based on the Nielsen Retail Audit (December 2025), DLADY commands a dominant 41.8% market share in the liquid milk segment, and a 25.1% share in the formula and toddler nutrition segment. In the broader drinking milk products category, Euromonitor identifies DLADY as the market leader in Malaysia, with retail value sales of drinking milk products reaching MYR 2.8 billion in 2025, growing at 4%.

---

Durable Competitive Advantages

1. Brand Equity with Deep Consumer Trust

DLADY was named "No. 1 Most Chosen Brand in the Dairy Category" by KANTAR Brand Footprint and "Brand of the Decade". Through the School Milk Programme, the company has distributed over 228 million packs of milk since 2011, reaching 4.7 million students and embedding the brand into Malaysian childhood nutrition. This multi-generational brand loyalty creates a powerful "habitual purchase" moat.

Its parent FrieslandCampina provides R&D firepower and continuous product innovation — evidenced by launches such as Dutch Lady Omega 3*6 for brain development, Frisomum with Lactoferrin, and Friso Gold Comfort Next for constipation management. The new on-site pilot plant at the Bandar Enstek facility further bolsters new product development capabilities.

2. Unmatched Distribution Scale & Operational Efficiency

DLADY's distribution reaches tens of thousands of retail touchpoints nationwide across hypermarkets, supermarkets, mini-markets, provision shops and e-commerce platforms. The newly commissioned Distribution Centre at Bandar Enstek (25,000-pallet capacity) integrates the distribution function under one roof, reducing reliance on external warehouses, improving delivery lead times and lowering logistics costs.

3. State-of-the-Art Manufacturing (Bandar Enstek Plant)

The company completed a MYR 600 million transition to its new IR4.0-enabled Bandar Enstek facility, fully operational from July 2024. Benefits include doubled production capacity to capture future demand, enhanced automation and layout design for streamlined production flows, and tax allowances on qualifying income attributable to Bandar Enstek-related operations. This plant is intended to become a regional manufacturing hub in collaboration with parent Royal FrieslandCampina.

4. Supply Chain Integration & Raw Material Security

The company imports key raw materials—primarily milk powders—from New Zealand (43%), Indonesia (43%) and the Netherlands (9%) to ensure consistent quality. The balance sheet is deleveraged following the completion of heavy capex, and moderated capex requirements going forward should support stronger free cash flow conversion.

5. ESG & Sustainability as Strategic Moat

DLADY achieved a 4-star FTSE4Good ESG Rating, placing it in the top quartile of Malaysian public listed companies. The company integrates sustainability across six pillars: Better Nutrition, Better Packaging, Better Sourcing, Better Climate, Better People and Better Governance. Strong ESG credentials enhance appeal to institutional investors and younger consumers increasingly prioritising sustainable brands.

---

Financial Analysis & Discussion

Executive Summary: 5-Year Performance Review

Revenue Analysis: Steady Growth Amid Market Volatility

Revenue Analysis: Steady Growth Amid Market Volatility

Revenue has grown progressively from MYR 1,134 million in 2021 to MYR 1,500 million in 2025, representing a 5-year CAGR of approximately 7.2%. The strongest growth occurred in 2022 (+18.1%), reflecting post-pandemic recovery and robust demand for dairy products. The modest 0.2% growth in 2024 was a direct result of plant transition disruptions—the temporary disruption in production during migration from Petaling Jaya to Bandar Enstek—which were fully resolved when the new plant became fully operational in July 2024.

The 2025 growth of 3.8% reflects the first full year of operations at the new facility, with Q3 2025 showing particularly strong momentum as revenue grew 5.4% year-on-year. Q1 2026 (MYR 398 million, +5.6% vs Q4 2025) suggests positive growth momentum continuing into FY2026.

Profitability: Margin Pressures and Recovery Path

Gross profit margin fluctuated significantly: 2021's exceptionally high margin (~35%) reflected extraordinary pandemic-related factors, which normalised to 26-30% from 2022 onward.

The earnings pressure in FY2022-2023 was driven by the Bandar Enstek plant transition, incurring substantial migration and start-up costs that suppressed EBIT and net income. EBIT plummeted to MYR 154 million in 2022 (from MYR 211 million in 2021), while net income collapsed to MYR 46 million (vs MYR 248 million in 2021—though note 2021 included substantial MYR 117 million unusual income, artificially inflating base earnings).

2024-2025 showed decisive recovery: Net income improved to MYR 97 million (+33.5%) in 2024 and further to MYR 103 million (+6.9%) in 2025. EBIT rebounded strongly from MYR 209 million in 2023 to MYR 265 million in 2024 and MYR 178 million in 2025. However, EBIT in 2025 appears lower relative to 2024 primarily due to one-off factors including MYR 21 million unusual expense (compared to MYR 8 million income in 2024) and higher interest expense (MYR 8 million, +25.5%). On a like-for-like basis excluding one-off transition costs, adjusted operating profit in Q3 2025 actually grew 17%.

The Q3 2025 quarter was particularly impressive, with net profit surging 86% year-on-year to MYR 32.1 million (vs MYR 17.2 million in Q3 2024), driven by substantially lower transition-related costs (MYR 1.7 million vs MYR 13.2 million), favourable exchange rates (strengthening MYR), and lower dairy raw material costs.

The net margin has stabilised at approximately 6.9% in 2025 (vs ~3-5% in 2022-2023 and the 21.9% anomaly in 2021). The Gross Profit Margin of 29.04% in 2025 sits within a reasonable long-term range for a major FMCG dairy company facing commodity price volatility.

Cost Structure and Operating Leverage

COGS as a percentage of revenue has generally been elevated in recent years (71-74% range) due to high dairy commodity prices, with 2025's 71% at the lower end of the band as raw material costs softened.

SG&A expenses grew from MYR 189 million in 2021 to MYR 258 million in 2025 (+36%), representing about 17% of revenue. This reflects the costs of supporting a larger revenue base and new facility operations.

Earnings Per Share and Shareholder Returns

EPS has rebounded strongly: MYR 0.72 (2022) → MYR 1.13 (2023) → MYR 1.51 (2024) → MYR 1.61 (2025). The company has maintained a consistent dividend of MYR 0.25 per share per quarter, representing an annual dividend of MYR 1.00 — a yield of approximately 3.3-4.0% depending on share price. With heavy capex now complete, analysts expect RHB Investment's projected >6% dividend yield in coming years as payout ratios normalise toward historical highs.

The ROE improved to 18% as of June 2025, a significant recovery from pandemic lows and consistent with pre-disruption levels.

Balance Sheet & Cash Flow Considerations

Leverage has moderated significantly. Cash and short-term investments more than doubled from MYR 48 million (2024) to MYR 93 million (2025). Receivables are well-managed at MYR 116 million, representing approximately 28 days of sales outstanding.

Free cash flow has been under pressure during the heavy capex cycle, with one analysis noting an accrual ratio of 0.27, indicating that free cash flow has not yet fully caught up with reported profits. However, with the MYR 600 million plant now complete and the Distribution Centre operational, capex requirements are expected to normalise, allowing free cash flow to increasingly align with net income.

---

Risks and Challenges

Commodity Price Volatility. Dairy raw material prices, while softening from earlier peaks, remain elevated and are subject to global supply-demand dynamics. The company's reliance on imported milk powders exposes it to currency fluctuations.

Sugar Tax Impacts. The expanded sugar tax (effective 2025) may affect flavoured milk drink sales, though the company's portfolio includes plain milk and healthier options that should mitigate the impact.

Intense Competition. The Malaysian dairy market features strong rivals including F&N, Nestlé, and Farm Fresh (the latter holding ~18% RTD market share). Farm Fresh's vertically integrated "grass-to-glass" model has gained consumer traction. However, DLADY's 41.8% liquid milk share comfortably exceeds any rival's position.

ESG and Regulatory Evolution. The expanded Sales and Services Tax scope is expected to add pressure to operating costs, partially offset by a strengthening MYR/USD exchange rate.

---

Outlook

The completion of the Bandar Enstek facility marks a structural inflection point. The doubled capacity, enhanced automation, integrated distribution centre, and ongoing tax allowances on qualifying income should drive meaningful margin expansion going forward. Analyst consensus for DLADY is "Strong Buy" with a 12-month price target of MYR 34.00.

Revenue is forecast to grow at 4.1% per annum over the next three years, exceeding the Malaysian food industry's 2.1% forecast. Earnings are expected to enter an upcycle from FY2026 onwards, driven by the full-year contribution of the new plant, easing input costs and firmer MYR exchange rates.

For a company with dominant market positions, globally backed R&D, best-in-class manufacturing infrastructure, and brand trust accumulated over six decades, Dutch Lady appears well-positioned to sustain and potentially expand its leadership in Malaysia's growing dairy market.

Scientex: unique twin-engine synergy

Scientex is a Malaysian conglomerate operating two core business engines: global flexible plastic packaging and domestic affordable housing property development. This twin-engine structure provides a natural hedge, as the property division consistently offsets cyclical volatility in the packaging market. Over the five‑year period shown (FY2021 to FY2025), revenue grew steadily from RM3.66 billion to RM4.52 billion, though net income declined slightly by 2.65% in FY2025 to RM531 million. The company is valued at RM5.52 billion, trades at a reasonable trailing P/E of 10.07x, and offers a dividend yield of 3.33%, highlighting its appeal as a stable income‑generating investment.

Looking at the two segments, the packaging manufacturing arm produces industrial stretch films and consumer packaging, with more than 40% of sales exported to Japan, Australia, and the US. In FY2025, packaging revenue was RM2.48 billion, down 4.3% due to intensified global competition. The property development segment focuses strictly on affordable homes (71% priced below RM300,000). Revenue increased 8.1% year‑on‑year to about RM2.03 billion in FY2025, supported by strong take‑up rates of 70‑80% and a record high unbilled sales of RM2.0 billion. The packaging segment contributed roughly 55% of total revenue in FY2025, though the profit split is moving closer to parity.

Scientex has built durable competitive advantages. 

1. First, its twin‑engine synergy is unique: in FY2025, when packaging profits fell, a 14% increase in the property division’s earnings offset the slump. 
2. Second, as a top global producer of stretch film, it enjoys economies of scale, allowing pricing power and sustained investment in automation and waste reduction. 
3. Third, its affordable housing model – low‑cost peripheral land and standardized mass construction – targets the resilient lower‑to‑middle‑income market, resulting in high take‑up and rapid cash conversion. 
4. Fourth, a new recurring income stream from a hotel portfolio in Japan provides 98% occupancy and 40‑50% operating margins through joint ventures.

Financially, Scientex has grown sales from RM3.66 billion to a record RM4.52 billion in FY2025, but net income in FY2025 (RM531 million) fell slightly short of the prior year’s record (RM545 million). Gross profit margin averaged a solid 23.38% in FY2025, indicating stable pricing power against input costs, though operating margins in packaging faced pressure, falling from about 9% to 6% due to global competition. Net margin remained healthy at 11.75%. The property division’s cash generation is fueling aggressive land bank expansion, which has raised net gearing but remains at a “healthy” level according to management. 

Shareholder returns improved: annual dividend per share increased to 8 sen for FY2025, a 33% rise from the previous year’s 6 sen. The most recent quarterly data (January 2026) shows sales of RM1.136 billion, net income of RM135 million, and diluted EPS of RM0.09, continuing the trend of modest near‑term pressure. 

In summary, Scientex is a well‑defended, diversified group that prioritises growth investments over short‑term profit maximisation, though investors should note that the packaging industry remains highly competitive and delays in property launches could affect cash flow. 

====

Latest quarterly results of Scientex 10/6/2026

Scientex delivered a resilient performance in the first nine months of FY2026, with revenue rising 2.5% to RM3.41 billion and net profit attributable to owners increasing 11.6% to RM420.3 million. The packaging division staged a strong recovery: although revenue remained stable at RM1.885 billion, operating profit jumped 57.9% to RM169.9 million, driven by improved market sentiment, better margins from a favourable product mix, and enhanced operational efficiency. The property division also performed steadily, with revenue up 4.8% to RM1.523 billion and operating profit rising modestly to RM429.8 million, supported by resilient take‑up rates and steady construction progress. On a quarter‑on‑quarter basis (third quarter ended 30 April 2026 compared to the preceding quarter), revenue dipped slightly by 1.6% to RM1.118 billion, but profit before tax rose 4.8% to RM199.2 million, again led by packaging margin improvement.

The cash flow statement, however, showed significant tightening. Net cash from operations fell to RM379.9 million from RM461.9 million a year earlier, due to larger increases in receivables and a bigger drop in payables. Investing activities recorded a net outflow of RM252.0 million, which included RM82.4 million for plant and equipment, RM132.8 million for a share capital reduction at subsidiary SPAK, and RM15.0 million for additional subsidiary interest – much smaller than the prior year’s RM1.52 billion outflow, which had included a RM1.3 billion land purchase. Financing activities saw a net outflow of RM418.5 million (compared to a large inflow of RM987.5 million in 9M FY2025), driven by repayment of short‑term borrowings (RM260.1 million), dividend payments, and the SPAK capital reduction. Consequently, cash and cash equivalents fell sharply from RM445.6 million in July 2025 to RM155.0 million at April 2026.

The balance sheet remained solid, with total assets of RM7.84 billion, total liabilities of RM3.27 billion, and equity attributable to owners rising to RM4.40 billion, pushing net assets per share from RM2.65 to RM2.83. Total borrowings stood at RM2.18 billion (RM1.06 billion long‑term, RM1.12 billion short‑term), giving a manageable debt‑to‑equity ratio of 0.48x. Minority interests dropped sharply from RM261 million to RM160 million following the completion of the selective capital reduction that made SPAK a wholly owned subsidiary, simplifying the group structure. The Board declared a single‑tier interim dividend of 6 sen per share for FY2026, payable on 17 July 2026, maintaining the same level as the previous year’s interim dividend.

Looking ahead, management expects both divisions to deliver satisfactory full‑year results. The packaging division faces ongoing geopolitical tensions and cost pressures but is mitigating risks through operational efficiency and cost optimisation. The property division has three new townships in its pipeline – Scientex Melaka, Scientex SP Astana, and Scientex Bestari Jaya – which are expected to support medium‑to‑long‑term growth. Key risks to monitor include the sharp decline in cash reserves, the sustainability of packaging margin improvements, and potential delays in property launches. Overall, Scientex appears on track for a satisfactory finish to FY2026, supported by a strong recovery in packaging and steady demand for affordable housing.

KPJ Healthcare: well managed but highly leveraged.

KPJ Healthcare is Malaysia’s largest private healthcare provider by network size, operating over 30 specialist hospitals across the country. Its primary business is the operation of specialist hospitals offering inpatient and outpatient services, diagnostics, pharmaceuticals, and health screenings, with a hub‑and‑spoke model that channels complex cases to flagship centres of excellence. Revenue is almost entirely generated by its Malaysian hospitals (~99% of total), while smaller non‑core segments include Indonesian operations (historically loss‑making), a healthcare education and training division (nursing college and university), and senior living care. The Indonesian division has accumulated net losses exceeding RM300 million over five years, prompting calls for divestment.

The company possesses several durable competitive advantages. Its network of more than 30 hospitals gives it a market share of roughly 20‑22% of Malaysia’s private hospital beds, a scale that is difficult for rivals to match. KPJ has announced plans to add 2,200 new beds by 2030, a 56% increase, further entrenching its leadership. This scale enables centralised procurement and shared services, lowering unit costs. A unique structural advantage is its 49% stake in Al‑`Aqar Healthcare REIT: mature hospitals can be sold to the REIT to free up capital for new projects while being leased back under long‑term master leases. Additionally, KPJ runs its own nursing college and university, creating a captive pipeline of trained healthcare professionals in a country facing a critical nursing shortage. However, these moats are narrow. The company has no pricing power in a highly competitive, regulated market; clinical outcomes are largely undifferentiated; and it remains heavily dependent on lower‑margin domestic general services rather than high‑value medical tourism.

Turning to the financial statements (annual data 2021‑2025, quarterly data through Q1 2026), revenue has grown from RM2.59 billion in 2021 to RM4.26 billion in 2025, a five‑year CAGR of about 13.2%, driven by higher patient volumes, outpatient visits, and a post‑COVID recovery in medical tourism. Net income expanded dramatically from RM55 million (net margin 2.12%) in 2021 to RM366 million (net margin 8.60%) in 2025, reflecting operating leverage and disciplined cost control. Gross margin held steady around 44‑45%, and EBITDA margin rose from approximately 18.6% to 23.03% over the same period. Quarterly data for 2025 shows a progressive build‑up: net income rose from RM57 million in Q1 to RM133 million in Q4, but Q1 2026 saw a sharp sequential decline to RM70 million, partly seasonal but still notable.

The greatest financial risk is the company’s leverage. Interest expense has been consistently high (RM194‑205 million annually). Interest coverage (EBIT/interest) improved from a dangerous 1.4x in 2021 to 3.5x in 2025, but this remains only moderate for a capital‑intensive hospital operator. A decline in EBIT could quickly push coverage below 2.0x, raising covenant concerns and limiting dividend capacity. Diluted EPS grew from RM0.01 in 2021 to RM0.08 in 2024‑2025, with growth rates of over 200% in 2022 (from a low base) moderating to 3‑34% in later years.

Key risks include execution of the aggressive bed expansion (adding 2,200 beds by 2030), potential regulatory changes from Malaysia’s new health insurance scheme pilot starting in 2026, and currency/geopolitical volatility affecting medical tourism, which contributed 6.2% of 2025 revenue.

In conclusion, KPJ Healthcare has delivered a remarkable financial turnaround since 2021, with margins and net income more than doubling. Its durable competitive advantages – scale, REIT‑enabled capital recycling, and a captive talent pipeline – create a narrow economic moat. However, the company remains highly leveraged, and its ambitious expansion plan carries execution risk that will likely pressure near‑term occupancy and free cash flow. The bull case relies on further operating leverage as new beds mature; the bear case points to a balance sheet that constrains strategic flexibility. The business appears well‑managed and operationally sound, but debt levels mean investors cannot ignore the downside risks.

Tanco: recent sell-off reflects a long-overdue reality check, not a buying opportunity.

Tanco Holdings—a company whose stock market valuation has become completely untethered from its deteriorating financial reality.

Summary

1. Share Price Collapse & Insider Trading

• Tanco's share price fell limit-down for two consecutive days, dropping from RM1.76 (June 3) to RM0.80 (June 9)—a 54% decline in just four trading days.

• RM6 billion was erased from market capitalization, which fell from ~RM10.8 billion to ~RM4.91 billion.

• Group Managing Director Datuk Seri Andrew Tan Jun Suan sold 24.63 million shares at RM1.555—a 40% premium over the day's peak market price of RM1.11 (and far above the closing price of RM0.80). This suggests an off-market or negotiated transaction.

• His brother, Edwin Tan Kium Suan (an executive director of subsidiaries), bought 7.64 million shares at the intra-day low of 78.5 sen (RM0.785).

• Between May 28 and June 9, Andrew Tan sold a net ~17.4 million shares (17.83M bought, 35.25M sold).

2. Valuation Disconnect

• Tanco is described as a "loss-making" company (though the article notes nine-month net profit of RM6.7M on RM122M revenue—marginal profitability).

• P/E ratio: 741.4x—extraordinary for any company, let alone one with weak cash flow.

• Price-to-net asset value: 18x—implying the market values Tanco at 18 times its book value, despite negative operating cash flow and opaque assets.

3. New Developments Announced Amid the Sell-Off

• Tanco signed an MOU with China Mobile International (CMI) to explore a 50 MW data centre in Port Dickson.

• It is also pursuing a Port Dickson Free Zone (PDFZ) industrial park, with up to RM250 million in financial assistance proposed for a JV with the Negeri Sembilan state authority.

• The AI container port project has been revised from a long-term lease to a port development concession model over ~180 acres. The EPCC contract (RM3.53 billion) was awarded to a unit of China Communications Construction Company (CCCC).

4. Regulatory Scrutiny

• Bursa Malaysia issued unusual market activity (UMA) queries in April and again on June 8 (after the crash). Tanco's response was vague: ongoing discussions, but no finalized announcement.

---

Commentary

1. The Stock Is a Pure Momentum Play, Not an Investment

The numbers speak for themselves:

• 741x P/E and 18x P/B for a company with negative operating cash flow for five straight years, thin profitability, and an equity base built on continuous dilution.

• The recent nine-month net profit of RM6.7M (on RM122M revenue) is tiny relative to a RM4.9 billion market cap. Even if annualized to ~RM9M, the P/E would still be >500x.

This valuation cannot be justified by any rational fundamental analysis. The stock was driven by speculation on the Midport AI port narrative, not by earnings or cash flow.

2. Insider Selling at a Premium While the Stock Crashes – A Major Red Flag

• Andrew Tan sold 24.63M shares at RM1.555—a price far above where the stock was trading intraday (RM1.11 peak, RM0.80 close). Who bought at that price? The article suggests a "direct business transaction," likely a negotiated off-market deal.

• Meanwhile, his brother bought at 78.5 sen—the bottom tick. The optics are poor: one brother sells high (off-market), the other buys low (on-market).

• Andrew Tan's net selling over the period (35.25M sold vs. 17.83M bought) suggests reduction of exposure by the group's controlling figure. That is not what confident insiders do.

3. The "New MOUs" Smell of Narrative Management

Tanco announced:

• A data centre MOU with China Mobile International – but MOUs are non-binding and exploratory. No concrete commitment.

• The Port Dickson Free Zone industrial park – requiring RM250M in financial assistance (i.e., more cash to be raised or borrowed).

• The port concession model revision – a positive structural change, but the EPCC contract value (RM3.53B) is indicative, not firm.

These announcements, coming as the stock crashed and Bursa issued UMA queries, appear designed to distract from the insider selling and valuation collapse. They provide no near-term cash flow or earnings visibility.

4. Bursa's UMA Queries and Tanco's Vague Responses

The company received two UMA queries in two months – a sign of extreme volatility and possible information asymmetry. Tanco's response ("ongoing discussions, no finalized announcement") is the standard non-answer. Regulators may take a closer look at the timing of the insider sales relative to the undisclosed "discussions."

5. The Fundamental Problem Has Not Changed

Despite the port, data centre, and free zone narratives, Tanco's core financial reality remains:

• Negative operating cash flow – cannot fund itself.

• Reliance on equity dilution – the share count has ballooned.

• Opaque assets – large "other assets" and long-term receivables.

• Thin profitability – RM6.7M net profit over nine months.

The AI port is years away from generating revenue. The data centre MOU is exploratory. The free zone needs RM250M. None of these address the immediate cash burn.

Final Verdict

In one sentence: Tanco's share price was a speculative bubble built on port hype and momentum trading; the insider selling during the crash and the company's chronically weak cash flow fundamentals suggest that the recent sell-off reflects a long-overdue reality check, not a buying opportunity.

Alibaba is in a transitional phase

The fiscal year 2026 financial statements for Alibaba, a Hong Kong-listed company, illustrate a firm in the midst of a deliberate strategic transition. The figures show a business navigating short-term profit pressures while investing heavily in long-term growth, anchored by its core e‑commerce operations and a rapidly expanding artificial intelligence and cloud division.

Alibaba’s business can be broken down into three core pillars. 

1. The largest revenue contributor is the China Commerce Group, which includes Taobao and Tmall. This segment combines traditional e‑commerce with quick‑commerce (Taobao Instant Delivery), the latter enjoying explosive growth. In the first quarter of 2026, the China Commerce Group accounted for approximately 53.5% of total revenue and grew 16% year‑on‑year. 
2. The second major segment is the Cloud Intelligence Group, which contributed about 16.1% of revenue and grew 34% year‑on‑year. Within this segment, AI‑related revenue exceeded 20% of the total and was growing at a triple‑digit pace, making cloud and AI the primary growth engines. 
3. The International Digital Commerce Group, comprising AliExpress, Lazada and Trendyol, represented around 13.1% of revenue with 10% growth. 

The remaining revenue comes from Cainiao logistics and other smaller initiatives, although this category has seen a decline due to strategic disposals of non‑core assets such as Sun Art and Intime. By shedding these non‑essential businesses, Alibaba is sharpening its focus on its core commerce and cloud operations, which has temporarily weighed on headline revenue growth.

Alibaba possesses several durable competitive advantages that create a powerful economic moat. 

1. First, its ecosystem functions as a “flywheel”. The vast e‑commerce platforms generate enormous transaction volumes and data, which feed into the cloud and logistics arms. This data improves merchant efficiency and consumer experience, which in turn strengthens the core commerce business. 
2. Second, network effects and data advantages are immense. With over 900 million active consumers and more than 10 million active sellers, Taobao and Tmall create strong gravitational pull for both sides of the market. The user data derived from this scale powers AI‑driven personalisation and advertising, delivering a superior shopping experience that rivals struggle to replicate. 
3. Third, vertical integration creates high switching costs. By owning the retail front‑end (Taobao/Tmall), the cloud infrastructure (Alibaba Cloud) and the logistics network (Cainiao), Alibaba offers a seamless, full‑stack solution. The cost and complexity of migrating away from this integrated platform lock in merchants and enterprise customers, ensuring long‑term stickiness.

Turning to the financial statements, fiscal year 2026 (ending March 2026) shows a period of transition. Annual revenue reached HK$1,124,719 million, a 4.56% increase over the previous year. This represents a return to steady growth after a slight contraction in fiscal year 2022, though the pace remains modest. Quarterly results show significant volatility, with the March 2026 quarter experiencing a sharp 12.10% revenue decline from the prior quarter, likely due to the disposal of non‑core assets which temporarily depressed top‑line results in line with the company’s strategic refocusing.

The most striking feature of the financials is the dramatic compression in profitability, revealing management’s decision to prioritise growth investments over short‑term earnings. Despite a gross profit margin of 39.48% and a net margin of 10.35%, net income for fiscal year 2026 fell to HK$116,358 million, a 16.76% decline from the previous year’s HK$139,780 million. The quarterly data is even more striking: in the fourth quarter of 2026 (ended March 31, 2026), GAAP net income fell sharply year‑on‑year as a direct result of heavy reinvestment. The earnings before interest and tax (EBIT) margin more than halved to just 5.8% in fiscal year 2026 from 14.7% in the prior year, primarily due to a 42.9% surge in selling, general and administrative expenses. These elevated investments are channelled into three main areas: AI and cloud infrastructure (heavy capital expenditure), instant retail (Taobao Instant Delivery, which is operating at a significant loss), and user experience initiatives to attract and retain customers in a competitive market.

Other key financial metrics include diluted earnings per share (EPS), which fell 16.40% to HK$6.05 in fiscal year 2026, mirroring the drop in net income. However, the effect was partially offset by a 12% reduction in outstanding shares (from 21.8 billion to 19.2 billion) due to aggressive share buybacks. The dividend of HK$1.05 per share, with an ex‑dividend date of June 11, 2026, indicates management’s confidence in the company’s cash flow despite the earnings decline. The price‑to‑earnings ratio of 19.33 is relatively moderate, especially considering the temporary earnings downturn, and the market capitalisation of approximately $291 billion suggests that investors are focused on Alibaba’s future potential rather than its current earnings.

In summary, the income statements depict a company undergoing a significant and deliberate strategic transformation. Alibaba is consciously trading short‑term profitability for long‑term growth by aggressively investing in its “User First, AI‑Driven” strategy. The China E‑commerce Group continues to demonstrate resilience and generate cash, although it faces intense competition from rivals such as PDD Holdings (Pinduoduo) and JD.com. The true highlight is the Cloud Intelligence Group, which is emerging as a powerful second growth engine, with AI‑related revenue accelerating at a triple‑digit pace. Alibaba is in a transitional phase, betting its future on becoming a leader in AI and cloud computing – a journey that carries execution risks but offers a potentially transformative payoff.

Key Stock Data

• P/E Ratio (TTM)

  19.33(06/09/26)

• EPS (TTM)

  ^$6.19

• Market Cap

  ^$290.96 B

• Shares Outstanding

  2.40 B

• Public Float

  N/A

• Yield

  0.86%(06/09/26)

• Latest Dividend

  ^$1.05(07/13/26)

• Ex-Dividend Date

  06/11/26

Short Interest (05/29/26)

• Shares Sold Short

  38.87 M

• Change from Last

  -2.01%

• Percent of Float

  N/A